Effects of intravenous glucagon-like peptide-1 on glucose control and hemodynamics after coronary artery bypass surgery in patients with type 2 diabetes

Am J Cardiol. 2008 Sep 1;102(5):646-7. doi: 10.1016/j.amjcard.2008.06.029.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Blood Glucose / drug effects*
  • Blood Glucose / metabolism
  • Coronary Disease / complications
  • Coronary Disease / physiopathology*
  • Coronary Disease / surgery
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Glucagon-Like Peptide 1 / administration & dosage*
  • Hemodynamics / drug effects*
  • Hemodynamics / physiology
  • Humans
  • Incretins / administration & dosage*
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Postoperative Period
  • Treatment Outcome

Substances

  • Blood Glucose
  • Incretins
  • Glucagon-Like Peptide 1